Menopause
Conference Coverage
Poor evidence for vaginal laser therapy
Despite the continuing popularity of “vaginal rejuvenation” laser therapy, studies have yet to find it equivalent to FDA-approved therapies like...
Latest News
Hormone changes: The star of every stage in women’s sleep
There’s still a lot of work to be done in terms of better defining the characteristics specific to each sleep disorder and how they relate to each...
Latest News
Early or delayed menopause and irregular periods tied to new-onset atrial fibrillation
Findings highlight the significance of considering the reproductive history of women while developing tailored screening and prevention strategies...
Guidelines
New ovulatory disorder classifications from FIGO replace 50-year-old system
Once an ovulatory disorder has been diagnosed, four basic categories provide a framework for classification.
From the Journals
Early menopause linked with increased risk of heart problems
A study of more than 1.4 million women revealed that the younger the age at menopause, the higher the risk of heart failure and atrial...
Clinical Review
How should you advise your 54-year-old patient about the use of HT?
And how would your recommendations change if she has certain cardiovascular or breast cancer risk factors?
Latest News
Does cannabis help with menopause symptoms?
Women with symptoms of menopause are turning to cannabis for help, researchers have found, despite a lack of evidence that the drug works for...
Guidelines
NAMS affirms value of hormone therapy for menopausal women
Recent research supports individualized care to maximize benefits and minimize risks.
Latest News
Routine weight counseling urged for women at midlife
“Midlife women gain weight at an average of approximately 1.5 pounds per year, which increases their risk for transitioning from normal or...
Latest News
Hormone therapy didn’t increase recurrence or mortality in women treated for breast cancer
Recurrence was increased with vaginal hormone therapy among those taking aromatase inhibitors.
Clinical Review
2022 Update on menopause
A review of new evidence on risks of synthetic progestins in menopausal women at average risk for breast cancer, advantages of...